Research Interests
cardiac function
,
health services, research/outc
,
medical technology/devices
Recent Publications
Manogue MR, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Turner SJ, Applegate RJ.
Bleeding avoidance strategy: transition from femoral to radial artery as the preferred access for cardiac procedures. The Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol.
2011;
57(14 Suppl 1):E1057.
Schafer P, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC, Applegate RJ.
Cost effectiveness of drug-eluting stents versus bare metal stents in clinical practice: effect of stent length and diameter [abstract]. J Am Coll Cardiol.
2011;
57(14 Suppl 1):E1184.
Turner S, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Manogue MR, Applegate RJ.
Cath lab utilization during transition to the radial artery as preferred access: the Wake Forest academic medical center experience [abstract]. J Am Coll Cardiol.
2011;
57(14 Suppl):E1269.
Schafer PE, Sacrinty MT, Little WC, Gandhi SK, Kutcher MA, Santos RM, Cecile AC, Applegate RJ.
Resource utilization for propensity matched radial and femoral catheterization and intervention [abstract]. J Am Coll Cardiol.
2011;
58(20 Suppl B):B146-B147.
Chin CT, Weintraub WS, Dai D, Mehta RH, Rumsfeld JS, Anderson HV, Messenger JC, Kutcher MA, Peterson ED, Brindis RG, Rao SV.
Trends and predictors of length of stay after primary percutaneous coronary intervention: a report from the CathPCI registry. Am Heart J.
2011;
162(6):1052-1061.
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Little WC.
Three-year comparison of drug-eluting versus bare metal stents [abstract]. J Am Coll Cardiol.
2009;
53(10 Suppl 1):A353.
Hayes KR, Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.
Clinical outcomes of bare metal stents versus drug-eluting stents target vessel revascularization: evidence for a high-risk bare metal stent cohort [abstract]. J Am Coll Cardiol.
2009;
53(10 Suppl 1):A317-A318.
Lambert ND, Sacrinty MT, Ketch TR, Turner SJ, Santos RM, Daniel KR, Applegate RJ, Kutcher MA, Sane DC.
Chronic kidney disease and dipstick proteinuria are risk factors for stent thrombosis in patients with myocardial infarction [abstract]. J Am Coll Cardiol.
2009;
53(10 Suppl 1):A319.
Santos RM, Sacrinty MJ, Kutcher MA, Gandhi SK, Little WC, Applegate RJ.
Drug-eluting stent versus bare metal stent use in patients with chronic kidney disease [abstract]. J Am Coll Cardiol.
2009;
53(10 Suppl 1):A393-A394.
Kutcher MA, Klein LW, Ou F-S, Wharton TP Jr, Dehmer GJ, Singh M, Anderson HV, Rumsfeld JS, Weintraub WS, Shaw RE, et al.
Percutaneous coronary interventions in facilities without cardiac surgery on site: a report from the National Cardiovascular Data Registry (NCDR). J Am Coll Cardiol.
2009;
54(1):16-24.
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Gandhi SK, Baki TT, Little WC.
'Off-label' stent therapy. J Am Coll Cardiol.
2008;
51(6):607-614.
Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.
Drug-eluting stents versus bare metal stents in saphenous vein grafts at 2 years [abstract]. J Am Coll Cardiol.
2008;
51(10 Suppl B):B78.
Gandhi SK, Kay JD, Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Little WC.
Drug-eluting stents for ST elevation myocardial infarction: evidence for benefit at two years [abstract]. J Am Coll Cardiol.
2008;
51(10 Suppl B):B1.
Graham SH, Applegate RJ, Gandhi SK, Sacrinty MT, Baki TT, Santos RM, Little WC, Kutcher MA.
Culprit vessel primary percutaneous coronary intervention for ST elevation myocardial infarction shorter door to balloon time [abstract]. J Am Coll Cardiol.
2008;
51(10 Suppl B):B61.
Kutcher MA, Klein LW, Wharton TP Jr, Singh M, Dehmer GJ, Anderson V, Rumsfeld JS, Weintraub WS, Peterson ED, Ohu F-S, et al.
Percutaneous coronary interventions at facilities without on-site cardiac surgery: a report from the National Cardiovascular Data Registry (NCDR) [abstract]. Circulation.
2008;
117(21):e432.
Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.
Prognostic implications of post percutaneous coronary intervention vascular complications [abstract]. Am J Cardiol.
2008;
102(8A Suppl):9i.
Applegate RJ, Sacrinty MT, Kutcher MA, Baki TT, Gandhi SK, Santos RM, Little WC.
Vascular complications following cardiac catheterization and coronary intervention 1998-2005: influence of gender [abstract]. J Am Coll Cardiol.
2007;
49(9 Suppl):193A.
Ketch TR, Turner SJ, Sacrinty MT, Lingle KC, Applegate RJ, Kutcher MA, Sane DC.
Derived fibrinogen versus brain natriuretic peptide and C-reactive protein as a predictor of events after myocardial infarction [abstract]. Circulation.
2007;
116(16 Suppl II):II-578-579.
Mehta SK, Frutkin AD, Milford-Beland S, Klein LW, Shaw RE, Weintraub WX, Krone RJ, Anderson HV, Kutcher MA, Marso SP.
Utilization of distal embolic protection in saphenous vein graft interventions (an analysis of 19,546 patients in the American College of Cardiology-National Cardiovascular Data Registry). Am J Cardiol.
2007;
100(7):1114-1118.
Applegate RJ, Sacrinty MT, Kutcher MA, Gandhi SK, Santos RM, Little WC.
Vascular complications 1998-2007: evidence for better outcomes [abstract]. Am J Cardiol.
2007;
100(8 Suppl 1):6L.
Applegate RJ, Sacrinty MT, Kutcher MA, Santos RM, Baki TT, Gandhi SK, Little WC.
Off-label DES vs. BMS treatment: outcomes at 2 years [abstract]. Am J Cardiol.
2007;
100(8 Suppl 1):159L.
Daniel KR, Kutcher MA, Applegate RJ, Herrington DM.
Clinical and angiographic risk factors for mechanical obstruction and no reflow following percutaneous coronary intervention [abstract]. Circulation.
2006;
114(18 Suppl):II-731-732.
McKee SA, Applegate RJ, Hoyle JR, Sacrinty MT, Kutcher MA, Sane DC.
Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention [abstract]. Circulation.
2006;
114(18 Suppl):II-644.
Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM.
Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Circulation.
2006;
114(18 Suppl):II-392.
Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM.
Vascular complications after cath and percutaneous coronary intervention: thrombin hemostatic patch versus manual compression [abstract]. Am J Cardiol.
2006;
98(8A Suppl):184M-185M.
Applegate RJ, Kutcher MA, Little WC, Sacrinty MT, Gandhi SK, Baki TT, Santos RM.
Drug-eluting stent treatment of patients with myocardial infarction--efficacy and safety at nine months [abstract]. Am J Cardiol.
2006;
98(8A Suppl):75M.
Ellis SG, Cannon LA, Mann T, Greenberg JD, DeMaio S, Goli V, Knapp W, McGarry T, Kutcher MA, Koglin J, et al.
Safety and efficacy of the polymer-based, paclitaxel-eluting TAXUS stent in complex lesions: two-year clinical results from the TAXUS V de novo trial [abstract]. Am J Cardiol.
2006;
98(8A Suppl):142M-1434M.
Leonard JC, Sacrinty MT, Applegate RJ, Little WC, Baki TT, Gandhi SK, Santos RM, Kutcher MA.
Timing of intervention in non-ST-segment elevation myocardial infarctions: nine month outcomes [abstract]. Am J Cardiol.
2006;
98(8A Suppl):80M-81M.
All Publications
For a listing of recent publications, refer to PubMed, a service provided by the National Library of Medicine.
For a list of earlier publications, visit the Carpenter Library Publication Search.